BBH Holdings Information

BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 14.12%, Gilead Sciences at 13.92%, Vertex Pharmaceuticals at 7.73%, Regeneron Pharmaceuticals at 7.11%, and argenx SE at 5.88%.

Total Holdings

Top 10 Percentage

69.01%

Asset Class

Equity

ETF Category

Health

Assets

381.17M

PE Ratio

23.29

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	14.12%	152,804
2	GILD	Gilead Sciences, Inc.	13.92%	388,117
3	VRTX	Vertex Pharmaceuticals Incorporated	7.73%	66,714
4	REGN	Regeneron Pharmaceuticals, Inc.	7.11%	35,949
5	ARGX	argenx SE	5.88%	26,716
6	IQV	IQVIA Holdings Inc.	4.35%	93,177
7	RVMD	Revolution Medicines, Inc.	4.20%	108,811
8	NTRA	Natera, Inc.	4.03%	73,557
9	INSM	Insmed Incorporated	3.91%	103,762
10	ALNY	Alnylam Pharmaceuticals, Inc.	3.77%	45,887
11	BIIB	Biogen Inc.	3.63%	75,061
12	UTHR	United Therapeutics Corporation	3.59%	23,735
13	ONC	BeOne Medicines AG	3.39%	40,416
14	MRNA	Moderna, Inc.	3.25%	225,761
15	ILMN	Illumina, Inc.	2.62%	74,753
16	BNTX	BioNTech SE	2.49%	89,621
17	INCY	Incyte Corporation	2.26%	88,317
18	NBIX	Neurocrine Biosciences, Inc.	1.89%	54,351
19	TECH	Bio-Techne Corporation	1.52%	95,318
20	CRL	Charles River Laboratories International, Inc.	1.34%	27,400
21	BMRN	BioMarin Pharmaceutical Inc.	1.32%	91,133
22	ICLR	ICON Public Limited Company	1.31%	42,502
23	QGEN	Qiagen N.V.	1.15%	105,771
24	TEM	Tempus AI, Inc.	1.14%	75,789
25	n/a	Us Dollar	0.09%	334,680

As of Apr 21, 2026